Memantine Market Growth Accelerated By Rising Prevalence Of Alzheimer's Disease

MEMANTINE MARKET
 Memantine Market

Memantine is a prescription drug used to treat moderate to severe Alzheimer's disease. It helps control symptoms such as memory loss, mood swings, and confusion. Memantine bonds to receptors in the brain to help block the effects of glutamate, a chemical messenger that can damage or kill nerve cells. If not controlled, too much glutamate can lead to nerve cell injury or death.

The global Memantine Market is estimated to be valued at Us$ 921.6 Mn in 2024 and is expected to exhibit a CAGR Of 5.2% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:


The prevalence of Alzheimer's disease is increasing rapidly across the globe. According to Alzheimer's Association, Alzheimer's and other dementias afflict more than 5 million Americans. This number is projected to rise to nearly 14 million by 2050. High incidence and increasing awareness of symptoms, diagnosis and available therapies for Alzheimer's disease is the key factor driving growth of the memantine market. Rising geriatric population is another major driver. Older people are at higher risk of Alzheimer's and other dementias. According to the UN estimates, the population aged 60 years and older is expected to more than double, from 962 million globally in 2017 to 2.1 billion in 2050.

Segment Analysis


In the memantine market, the Alzheimer's disease segment dominates currently due to the higher prevalence of the disease among the aging population. According to WHO, around 50 million people worldwide are living with dementia and nearly 10 million new cases of dementia are reported each year globally. Alzheimer's disease accounts for 60–80% of dementia cases hence the demand for memantine medication is substantially high for treating moderate to severe Alzheimer's disease patients.

Key Takeaways


The Global Memantine Market Demand is expected to witness high growth over the forecast period driven by rising cases of Alzheimer's disease globally.

Regionally, North America holds the largest share in the memantine market currently owing to factors such as aging demography, affordability to healthcare expenditures and availability of reimbursement for Alzheimer's drugs.

Key players operating in the North America memantine market are Allergan, Merz Pharma GmbH & Co. KGaA, Novartis AG, Daiichi Sankyo Company, Limited and Jubilant Pharmova Limited.

Get more insights on this topic :

https://www.insightprobing.com/the-growing-demand-for-alzheimers-disease-drugs-drives-the-memantine-market/

Check more trending articles on this topic:

https://lotstoexpress.com/gummy-bliss-tasty-health-booster-for-a-vibrant-you-chewable-wellness-wonder/

Comments

Post a Comment

Popular posts from this blog

The Global Ebola Vaccine Market Is Estimated To Grow At Highest Pace Owing To Rising Ebola Cases

Image
  Ebola Vaccine Market   Ebola vaccines help in preventing Ebola virus disease which is a severe, often fatal illness in humans. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. Ebola vaccines provide protection by training the immune system to recognize and fight the Ebola virus. The need for Ebola vaccines has been increased recently owing to rising cases of Ebola outbreaks across Africa. The global  Ebola Vaccine Market  is estimated to be valued at  Us$ 6.72 Bn  in 2024 and is expected to exhibit a  CAGR Of 9.4%  over the forecast period  2024 To 2030 . Key Takeaways Key players operating in the  Ebola Vaccine Market   are 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, Diagenode. Key players are focused on developing improved and more effective Ebola vaccines to...
Read more

Aseptic Processing Market Is Estimated To Witness High Growth Owing To Increasing Demand For Sterile Products

Image
  Aseptic Processing Market The global Aseptic Processing Market is estimated to be valued at US$ 85 Billion in 2022 and is expected to exhibit a CAGR Of 9.2% over the forecast period 2023-2030 , as highlighted in a new report published by Coherent Market Insights. Market Overview: Aseptic processing involves the sterilization of products and packaging materials to eliminate the risk of contamination. It is widely used in the healthcare industry for the production of sterile pharmaceuticals, vaccines, and medical devices. The advantages of aseptic processing include extended shelf life, preservation of nutritional value, and maintenance of the overall quality and integrity of the products. With the increasing demand for safe and effective healthcare products, the need for aseptic processing is also growing. Market Key Trends: One key trend driving the aseptic processing market is the rising demand for sterile products. The healthcare industry, particularly pharmaceutical a...
Read more

Growing Demand Accelerated By Enhanced Customer Support. Chatbots Are Intelligent Artificial Assistant Designed To Have Natural Conversations To Provide Support To Customer

Image
Chatbot Market Chatbots can be used by any organization across different sector to provide 24/7 customer assistance, improve customer satisfaction and reduce operational cost. The global  Chatbot Market  is estimated to be valued at  Us$ 6.04 Billion  in 2024 and is expected to exhibit a  CAGR Of 6.3%  over the forecast period  2023 To 2030 , as highlighted in a new report published by Coherent Market Insights. Market key trends: Customer demand for engaging digital customer support services has been a key factor driving the growth of chatbot market. Chatbots are AI powered solution that offers 24/7 support to customers through messaging platform. They can understand customer queries, respond instantly and provide solution for common issues without any wait time. This has enabled organizations to enhance customer satisfaction levels and retain existing customers by offering immediate support. Chatbots also learn from past customer interactions which he...
Read more